These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 7599335)

  • 61. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
    Agrawal NM; Aziz K
    J Rheumatol Suppl; 1998 May; 51():17-20. PubMed ID: 9596550
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs].
    Stock KP; Bach GL
    Z Rheumatol; 1988; 47(3):177-81. PubMed ID: 3213266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
    Laine L
    Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk factors for gastrointestinal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).
    Agrawal N
    J Fam Pract; 1991 Jun; 32(6):619-24. PubMed ID: 2040888
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-steroidal anti-inflammatory drug-induced gastroduodenal injury: therapeutic recommendations.
    Curtis WD; Griffin JW
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():99-109. PubMed ID: 1679675
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Peptic ulcers in the elderly: unique features and management.
    Freston MS; Freston JW
    Geriatrics; 1990 Jan; 45(1):39-42, 45. PubMed ID: 2403956
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [NSAID-induced ulcers--therapy and prevention].
    Rösch W
    Z Rheumatol; 1995; 54(1):2-8; discussion 9-11. PubMed ID: 7725807
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Current state of treatment and prevention of gastroduodenal side effects of non-steroidal antirheumatic drugs].
    Bolten W
    Leber Magen Darm; 1991 Sep; 21(5):193-4, 196. PubMed ID: 1758234
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pharmacology of preventive and therapeutic drugs for NSAIDs ulcers in the gastrointestinal tract].
    Naito Y; Takagi T; Yoshikawa T
    Nihon Rinsho; 2011 Jun; 69(6):1007-15. PubMed ID: 21688620
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Prevention and treatment of nonsteroidal anti-inflammatory drugs induced ulcers].
    Kobayakawa M; Uemura N
    Nihon Rinsho; 2007 Oct; 65(10):1857-61. PubMed ID: 17926536
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Primary prevention of ulcers in patients taking aspirin or NSAIDs.
    Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.
    Lazzaroni M; Bianchi Porro G
    Dig Liver Dis; 2001 Dec; 33 Suppl 2():S44-58. PubMed ID: 11827362
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [NSAID ulcer (H. pylori, treatment, prevention)].
    Ohta S; Arai S; Imai Y; Banba H
    Nihon Rinsho; 2004 Mar; 62(3):505-11. PubMed ID: 15038095
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.
    Naesdal J; Wilson I
    Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1401-6. PubMed ID: 11742186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Making sense of NSAID gastropathy and considering the therapeutic options.
    Agrawal NM
    Scand J Rheumatol Suppl; 1992; 92():13-9. PubMed ID: 1349444
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevention of the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: the role of proton pump inhibitors.
    Brown GJ; Yeomans ND
    Drug Saf; 1999 Dec; 21(6):503-12. PubMed ID: 10612273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.